The DROP‐AD project: AD biomarkers from dry blood spots
This study demonstrates the feasibility of detecting and accurately quantifying AD biomarkers from capillary blood. The results suggest that this simple and temperature-independent approach could facilitate the identification of individuals at high risk for AD pathology, broadening access to biomarker testing in research settings.
Authors
- Hanna Huber (ORCID: https://orcid.org/0009-0004-3080-6870)
- Wagner S. Brum (ORCID: https://orcid.org/0000-0002-9777-0559)
- Xavier Morató (ORCID: https://orcid.org/0000-0002-3012-2864)
- Laia Montoliu‐Gaya (ORCID: https://orcid.org/0000-0001-7684-6318)
- Anna Dittrich (ORCID: https://orcid.org/0000-0002-5168-2975)
- Millie Sander
- Kaj Blennow
- Barbara Borroni (ORCID: https://orcid.org/0000-0001-9340-9814)
- Oskar H. Hansson
- Juan M. Fortea (ORCID: https://orcid.org/0000-0002-1340-638X)
- Anne Corbett
- Anja Hviid Simonsen
- Silke Kern
- Mercè Boada
- Sebastian Palmqvist
- Nicholas J. Ashton
- Henrik Zetterberg
Institutions
- Lund University (SE)
- University of Exeter (GB)
- Sahlgrenska University Hospital (SE)
- Hospital de Sant Pau (ES)
- Copenhagen University Hospital (DK)
- Universitat Internacional de Catalunya (ES)
- Region Västra Götaland (SE)
- Skåne University Hospital (SE)
- Banner Alzheimer’s Institute
- University of Brescia (IT)
- University of Gothenburg (SE)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102258
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00